Advertisement
Canada markets close in 5 hours 25 minutes
  • S&P/TSX

    21,824.85
    +116.41 (+0.54%)
     
  • S&P 500

    4,995.04
    -16.08 (-0.32%)
     
  • DOW

    37,921.69
    +146.31 (+0.39%)
     
  • CAD/USD

    0.7282
    +0.0018 (+0.25%)
     
  • CRUDE OIL

    83.09
    +0.36 (+0.44%)
     
  • Bitcoin CAD

    88,254.70
    +980.49 (+1.12%)
     
  • CMC Crypto 200

    1,376.58
    +63.96 (+5.13%)
     
  • GOLD FUTURES

    2,404.30
    +6.30 (+0.26%)
     
  • RUSSELL 2000

    1,949.77
    +6.82 (+0.35%)
     
  • 10-Yr Bond

    4.6290
    -0.0180 (-0.39%)
     
  • NASDAQ

    15,446.03
    -155.47 (-1.00%)
     
  • VOLATILITY

    18.77
    +0.77 (+4.28%)
     
  • FTSE

    7,874.57
    -2.48 (-0.03%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

4 Times When Cannabis Companies Badly Missed Their Forecasts

4 Times When Cannabis Companies Badly Missed Their Forecasts

It's easy for investors to get caught up in the hype surrounding the cannabis industry, especially when expectations are sky-high. There are plenty of examples of cannabis companies falling short of their own expectations. In April 2019, then-CEO Bruce Linton projected that Canopy Growth (NYSE: CGC) would generate over 1 billion Canadian dollars ($744 million) in revenue over a 12-month period starting April 1, 2019, which is the start of the company's fiscal year.